JURÁČEK, Jaroslav, Marie MĄDRZYK, Karolína TRACHTOVÁ, Michaela RUČKOVÁ, Júlia BOHOŠOVÁ, Dominik A. BARTH, Martin PICHLER, Michal STANÍK and Ondřej SLABÝ.
Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome.
CANCER GENOMICS & PROTEOMICS. ATHENS: INT INST ANTICANCER RESEARCH, 2023, vol. 20, No 3, p. 308-316. ISSN 1109-6535. doi:10.21873/cgp.20383
Drula R, Pardini B, Fu X, De Los Santos MC, Jurj A, Pang L, El-Daly SM, Fabris L, Knutsen E, Dragomir MP, Bayraktar R, Li Y, Chen M, Del Vecchio F, Berland L, Dae J, Fan D, Shimizu M, Tran AM, Barzi M, Pioppini C, Gutierrez AM, Ivan C, Meas S, Hall CS, Alahari SK, Berindan-Neagoe I, Fabbri M, Lucci A, Arun B, Anfossi S, Calin GA.
17β-estradiol promotes extracellular vesicle release and selective miRNA loading in ERα-positive breast cancer
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, Vol.120, Issue 23, ISSN 0027-8424, doi:10.1073/pnas.2122053120
Bianca Oana Pirlog, Silvina Ilut, Radu Pirlog, Paul Chiroi, Andreea Nutu, Delia Ioana Radutiu, George Daniel Cuc, Ioana Berindan-Neagoe, Seyed Fazel Nabavi, Rosanna Filosa, Seyed Mohammad Nabavi
New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs
EXPERT REVIEWS IN MOLECULAR MEDICINE, 2023, Vol. 25, ISSN 1462-3994, doi: 10.1017/erm.2023.10
A Jurj, D Qian, G A Calin, K Litchfield
At the crossroad between checkpoint blockade and big data analyses: identification of novel biomarkers and potential targets
ANNALS OF ONCOLOGY, 2022, Vol. 33, Issue 12, ISSN 0923-7534, doi10.1016/j.annonc.2022.10.507
DRULA, R., R. PIRLOG, M. TRIF, Ondřej SLABÝ, C. BRAICU and I. BERINDAN-NEAGOE.
circFOXO3: Going around the mechanistic networks in cancer by interfering with miRNAs regulatory networks.
Biochimica et Biophysica Acta - Molecular Basis of Disease. Amsterdam: ELSEVIER SCIENCE BV, 2021, vol. 1867, No 5, p. 166045-166051. ISSN 0925-4439. doi:10.1016/j.bbadis.2020.166045.
BARTH, D.A., R. DRULA, L. OTT, L. FABRIS, Ondřej SLABÝ, G.A. CALIN and M. PICHLER.
Circulating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical Biomarkers.
Frontiers in Cell and Developmental Biology. Lausanne: Frontiers Media S.A., 2020, vol. 8, SEP, p. 828-843. ISSN 2296-634X. doi:10.3389/fcell.2020.00828.
JURJ, A., C. POP-BICA, Ondřej SLABÝ, C. D. STEFAN, W. C. CHO, S. S. KORBAN and I. BERINDAN-NEAGOE.
Tiny Actors in the Big Cellular World: Extracellular Vesicles Playing Critical Roles in Cancer.
International Journal of Molecular Sciences. Basel: Multidisciplinary Digital Publishing Institute, 2020, vol. 21, No 20, p. 1-27. ISSN 1422-0067. doi:10.3390/ijms21207688.
DRULA, R., C. BRAICU, A. HARANGUS, S.M. NABAVI, M. TRIF, Ondřej SLABÝ, C. IONESCU, A. IRIMIE and I. BERINDAN-NEAGOE. |
BRAICU, C., M. BUSE, C. BUSUIOC, R. DRULA, D. GULEI, L. RADULY, A. RUSU, A. IRIMIE, A.G. ATANASOV, Ondřej SLABÝ, C. IONESCU and I. BERINDAN-NEAGOE.
A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer.
Cancers. BASEL: MDPI, 2019, vol. 11, No 10, p. 1618-1642. ISSN 2072-6694. doi:10.3390/cancers11101618.
BARTH, D.A., Ondřej SLABÝ, C. KLEC, Jaroslav JURÁČEK, R. DRULA, G.A. CALIN and M. PICHLER.
Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma.
Cancers. BASEL: MDPI, 2019, vol. 11, No 10, p. 1580-1598. ISSN 2072-6694. doi:10.3390/cancers11101580
KŘEPELKOVÁ, Iveta, Tereza BÁŤKOVÁ, Jitka KŘÍŽÁKOVÁ, B. DVORAKOVA, L. CHALUPOVA, Robert MIKULÍK, Ondřej SLABÝ, Milan BARTOŠ and V. RUZICKA.
Evaluation of miRNA detection methods for the analytical characteristics necessary for clinical utilization.
Biotechniques. New York: Biotechniques Office, 2019, vol. 66, No 6, p. 277-284. ISSN 0736-6205. doi:10.2144/btn-2019-0021
IRIMIE-AGHIORGHIESEI, Alexandra Iulia, Cecilia POP-BICA, Sebastian PINTEA, Cornelia BRAICU, Roxana COJOCNEANU, Alina-Andreea ZIMTA, Diana GULEI, Ondřej SLABÝ and Ioana BERINDAN-NEAGOE.
Prognostic Value of MiR-21: An Updated Meta-Analysis in Head and Neck Squamous Cell Carcinoma (HNSCC).
Journal of Clinical Medicine. BASEL: MDPI, 2019, vol. 8, No 12, p. 1-17. ISSN 2077-0383. doi:10.3390/jcm8122041.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska- Curie grant agreement no. 824036 – RNADIAGON.
This website reflects only the author's view and the Research Executive Agency (REA) is not responsible for any use that may be made of the information it contains.